DEATH AUDIT- DECEMBER 2016
Dr. Sujay Iyer
I Year PG
General Medicine IV
PATIENT DETAILS
 Name: Mr. Kannan
 Age/ Gender: 73 years/ Male
 MR number: 16/403522
 IP number: 16/061888
 DOA: 18/12/2016 at 22:34
 DOD: 23/12/016 at 13:40
 Duration of Stay: 5 days.
PRESENTING COMPLAINTS
 Shortness of breath
 Giddiness
 Generalised weakness
 Easy fatigability
 Decreased urine output
 Vomiting
HISTORY OF PRESENTING ILLNESS
 Patient presented to the ER with complaints of
shortness of breath since 4 days, NYHA grade IV.
 H/O Vomiting 4 days back on consumption of food.
Non-projectile, non-billous, non-blood stained,
consisting of food particles.
 H/O increased frequency of micturition with poor
urine output.
 No H/O chest pain, palpitations, diaphoresis,
syncope, orthopnea, PND.
 No H/O fever, loose stools, abdominal pain.
 No H/O burning micturition, dysuria.
 No H/O cough with expectoration
PAST HISTORY
 K/C/O Hypertension since 6 years. On T.
Amlodipine 5mg P/O OD.
 K/C/O Old CVA, 6 years back. Resolved
completely.
 Not a K/C/O Diabetes Mellitus, Bronchial Asthma,
Tuberculosis, Coronary Artery Disease.
 Not an Alcoholic or Smoker.
GENERAL EXAMINATION
 HR: 108/min.
 BP: 110/60 mmHg
 RR: 18/min.
 SpO2: 96% on room air.
 Temp: 99*F
 CBG: 112 mg%.
 Pallor (++), Pedal edema (+)
 No icterus, cyanosis, edema, lymphadenopathy.
SYSTEMIC EXAMINATION
 R/S: NVBS. No added sounds.
 CVS: S1S2 (+). No S3. No murmurs.
 P/A: Soft, non-tender, no organomegaly.
 CNS: Conscious, oriented.
Left plantar - Extensor.
Power - 5/5 in all 4 limbs.
INITIAL INVESTIGATIONS
PATHOLOGY BIOCHEMISTRY OTHERS
CBC:
Hb – 4.0
PCV – 14.2
MCH – 18.1
Plat – 2.31
TC – 10,900
URINE ROUTINE:
Albumin – Trace
RBC – Nil
Pus cells – 2 to 4
Epithelial cells – 2 to 4
Bacteria - Nil
RFT:
Urea- 87
Creat- 1.67
ELECTROLYTES:
Na – 132
K – 6.0
Cl – 103
CARDIAC MARKERS:
CPK T – 691
CPK MB - 38
ECG:
LBBB with tall T
waves.
CXR:
Increased
bronchovascular
markings.
Normal lung
parenchyma
ABG:
pH – 7.40
pO2 – 88
pCO2 – 23
HCO3 - 14
CHEST X-RAY
ECG
PROVISIONAL DIAGNOSIS
 Anemia for evaluation.
 Acute kidney injury with hyperkalemia.
INITIAL TREATMENT
 Inj. 10% Calcium Gluconate 10ml IV over 10 min.
 Inj. 25% Dextrose 100 ml with Inj. Actrapid 10 U IV
over 1 hour.
 Nebulisation with Salbutamol 1 respule P/N 1-1-1-.
 K-Bind Sachet 15 g in ½ glass of Water P/O 1-1-1.
 Transfusion with 1 unit of PRBC.
 Inj. Pantoprazole 40 mg P/O 1-0-0.
 T. Albendazole 400 mg P/O stat.
 Admitted in A0 under GM IV because of
unavailability of beds in MICU.
FURTHER PLAN
 USG Abdomen
 2D ECHO
 Repeat Potassium after 4 hours.
 LFT
 Ca, Mg, Ph, Uric Acid
 Stool for occult blood and ova cysts
 Peripheral smear with reticulocyte count.
19/12/2016
 Patient complained of easy fatiguability and
weakness.
 O/E:
 HR - 112/min. BP – 100/60. RR – 22/min. SpO2 – 98%.
I/O – 477/1000.
 Pallor (++)
 Bilateral pitting edema (+)
 Occasional bilateral basilar crepitations (+)
 Patient’s LFT was found to be elevated. USG
abdomen was planned and MGE opinion was to be
sought after.
 Patient was shifted to MMW D4.
INVESTIGATIONS
PATHOLOGY BIOCHEMISTRY BIOCHEMISTRY
Hb: 4.8
PERIPHERAL SMEAR:
Microcytic hypochromic
RBCs.
Anisopoikilocytosis (+)
Elliptocytes (+)
TC is raised with
neutrophilic
predominance.
Adequate platelets.
No parasites.
Reticulocyte count – 2%.
SEROLOGY: (-)
Urea: 80
Creat: 1.3
Na: 131
K: 5.1, 5.1
SGOT: 1830, 2710
SGPT: 3270, 1942
AlkP: 95, 111
GGT: 83
T.Prot: 6.0
Alb: 3.8
Glob: 2.2
T. Bil: 0.9
Ca: 9.8
Ph: 2.9
Mg: 1.8
Uric acid: 8.6
PT: 30.6 (13.5)
INR: 2.42
PTT: 47.5 (32)
CPK T: 439
CPK MB: 16
20/12/16
 Patient was symptomatically stable.
 O/E:
 HR: 110/min. BP: 110/80 mmHg.
 Pallor (++). Icterus (+). B/L Pitting edema (+).
 R/S: NVBS. Bil Crepts (+). More on left side.
 Repeat CXR was advised. One unit of PRBC was
transfused.
 USG Abdomen:
 Mild fatty liver with GB wall edema. Bilateral simple renal
cortical cysts. Minimal left sided pleural effusion.
 MGE opinion: Hepatomegaly (+). ?Hemolytic cause to
r/o malignancy. ?HCC. To do LDH, AFP and CECT. To
add Udiliv and Silybon & stop Propranolol.
TREATMENT DETAILS
 Inj. Furosemide 40 mg IV 1-1-0
 Inj. Thiamine 100 mg IV 1-0-1
 T. Rifaximin 400 mg PO 1-0-1
 T. Propranolol 20 mg PO 1-0-1 (Stopped)
 T. Ferrous Sulphate 1 tab PO 1-0-1
 T. B-Complex 1 tab PO 1-0-0
 Syp. Lactulose 30 ml PO 1-0-1.
 Inj. Vitamin K 1 amp. IV 1-0-1.
 T. Udiliv 300 mg Po 1-0-1
 T. Sliybon 140 mg PO 1-0-1.
21/12/16
 Patient complained of hiccups.
 O/E:
 HR: 106/min. BP: 110/80 mmHg.
 Pallor (+). Pedal edema (+).
 R/S: Bilateral crepts (+)
 P/A: Hepatomegaly (+)
 2D ECHO:
 All chambers dilated. Severe LV dysfunction. LVEF of
21%. Grade III Diastolic dysfunction. Trivial AR and TR.
Global hypokinesia of LV. No RWMA. No clots. No
vegetations.
 Repeat CBC, RFT, SE were sent.
21/12/16
 At 3 30 pm, patient developed high-grade fever and
dyspnea.
 O/E:
 HR: 119/min. BP: 130/80 mmHg. Temp: 103*F. RR:
22/min. SpO2: 82% on room air and 99% with 40%
FiO2.
 R/S: NVBS. Bilateral crackles (+).
 ABG: Respiratory Alkalosis with metabolic acidosis.
(pH – 7.46, pCO2 – 23, pO2 – 136, HCO3 – 17)
 ECG: No new ST-T changes. LBBB.
 Hb – 6.0. TC – 21,700. Plat – 73,000 (verbal).
 Na: 129. K: 4.9. Cl: 102. Urea: 68. Creat: 1.12
21/12/16
 Impression: Sepsis. Anemia in failure. Severe LV
dysfunction. Thrombocytopenia for evaluation.
 Patient shifted to sick cubicle in MMW D4.
 Oxygen support of 25% FiO2.
 Urine Routine, Blood and Urine C/S, Rapid card
test for Malaria, MP/MF and Dengue Serology sent.
 Inj. Cefoperazone + Sulbactam 1.5 g IV BD started.
 C. Doxycycline 100 mg PO BD started.
22/12/16
 Patient’s dyspnea reduced. C/O Hiccups (+).
 O/E:
 HR: 108.min. BP: 140/70 mmHg.
 R/S: Bilateral crackles reduced.
 Inj. Metoclopromide 5 mg IV 1-1-1 added.
 Dengue serology (-).
 Malaria tests (-).
INVESTIGATIONS
21/12/16 23/12/16
Hb: 6.0
TC: 17,360
Plat: 73,000
Urea: 68
Creat: 1.12
Na: 129
K: 4.9
Cl: 102
Malaria (-)
Dengue (-)
Urine C/S: Sterile
Blood C/S: Coagulase negative
Staphylococcus sensitive to all
antibiotics except Penicillin &
Tetracycline
Hb: 7.1
Plat: 71,000
Urea: 41
Creat: 1.19
Na: 132
K: 3.1
Cl: 99
ABG:
pH – 7.06
pCO2 – 56
pO2 – 79
HCO3 – 15.9
AFP (-)
LDH (+) [4000]
23/12/16
 Patient’s dyspnea reduced. Hiccups still (+).
 O/E:
 HR: 123/min. BP: 110/70 mmHg. SpO2: 98% on 25%
FiO2.
 R/S: NVBS. Bilateral crackles decreased.
 HB: 7.1. Plat: 70,000. RFT and SE normal.
 Plan for Cardiology opinion post-rounds.
23/12/16
 Patient found to be gasping. Call received during
rounds at 12:30 pm.
 HR: 132/min. SpO2: 85% with 60% FiO2 and
steadily falling. Peripheral pulse not palpable.
 CPR was immediately started according to ACLS
protocol.
 Patient was intubated with 6.5’ ET tube.
 CPR was continued.
 Patient was shifted to ICU for resucitation.
 Despite all efforts, patient could not be revived and
was declared expired at 13:41.
CAUSE OF DEATH
 CONGESTIVE CARDIAC FAILURE
 SYSTEMIC HYPERTENSION
 MICROCYTIC HYPOCHROMIC ANEMIA
 OLD CVA
THANK YOU

Mr. Kannan

  • 1.
    DEATH AUDIT- DECEMBER2016 Dr. Sujay Iyer I Year PG General Medicine IV
  • 2.
    PATIENT DETAILS  Name:Mr. Kannan  Age/ Gender: 73 years/ Male  MR number: 16/403522  IP number: 16/061888  DOA: 18/12/2016 at 22:34  DOD: 23/12/016 at 13:40  Duration of Stay: 5 days.
  • 3.
    PRESENTING COMPLAINTS  Shortnessof breath  Giddiness  Generalised weakness  Easy fatigability  Decreased urine output  Vomiting
  • 4.
    HISTORY OF PRESENTINGILLNESS  Patient presented to the ER with complaints of shortness of breath since 4 days, NYHA grade IV.  H/O Vomiting 4 days back on consumption of food. Non-projectile, non-billous, non-blood stained, consisting of food particles.  H/O increased frequency of micturition with poor urine output.  No H/O chest pain, palpitations, diaphoresis, syncope, orthopnea, PND.  No H/O fever, loose stools, abdominal pain.  No H/O burning micturition, dysuria.  No H/O cough with expectoration
  • 5.
    PAST HISTORY  K/C/OHypertension since 6 years. On T. Amlodipine 5mg P/O OD.  K/C/O Old CVA, 6 years back. Resolved completely.  Not a K/C/O Diabetes Mellitus, Bronchial Asthma, Tuberculosis, Coronary Artery Disease.  Not an Alcoholic or Smoker.
  • 6.
    GENERAL EXAMINATION  HR:108/min.  BP: 110/60 mmHg  RR: 18/min.  SpO2: 96% on room air.  Temp: 99*F  CBG: 112 mg%.  Pallor (++), Pedal edema (+)  No icterus, cyanosis, edema, lymphadenopathy.
  • 7.
    SYSTEMIC EXAMINATION  R/S:NVBS. No added sounds.  CVS: S1S2 (+). No S3. No murmurs.  P/A: Soft, non-tender, no organomegaly.  CNS: Conscious, oriented. Left plantar - Extensor. Power - 5/5 in all 4 limbs.
  • 8.
    INITIAL INVESTIGATIONS PATHOLOGY BIOCHEMISTRYOTHERS CBC: Hb – 4.0 PCV – 14.2 MCH – 18.1 Plat – 2.31 TC – 10,900 URINE ROUTINE: Albumin – Trace RBC – Nil Pus cells – 2 to 4 Epithelial cells – 2 to 4 Bacteria - Nil RFT: Urea- 87 Creat- 1.67 ELECTROLYTES: Na – 132 K – 6.0 Cl – 103 CARDIAC MARKERS: CPK T – 691 CPK MB - 38 ECG: LBBB with tall T waves. CXR: Increased bronchovascular markings. Normal lung parenchyma ABG: pH – 7.40 pO2 – 88 pCO2 – 23 HCO3 - 14
  • 9.
  • 10.
  • 11.
    PROVISIONAL DIAGNOSIS  Anemiafor evaluation.  Acute kidney injury with hyperkalemia.
  • 12.
    INITIAL TREATMENT  Inj.10% Calcium Gluconate 10ml IV over 10 min.  Inj. 25% Dextrose 100 ml with Inj. Actrapid 10 U IV over 1 hour.  Nebulisation with Salbutamol 1 respule P/N 1-1-1-.  K-Bind Sachet 15 g in ½ glass of Water P/O 1-1-1.  Transfusion with 1 unit of PRBC.  Inj. Pantoprazole 40 mg P/O 1-0-0.  T. Albendazole 400 mg P/O stat.  Admitted in A0 under GM IV because of unavailability of beds in MICU.
  • 13.
    FURTHER PLAN  USGAbdomen  2D ECHO  Repeat Potassium after 4 hours.  LFT  Ca, Mg, Ph, Uric Acid  Stool for occult blood and ova cysts  Peripheral smear with reticulocyte count.
  • 14.
    19/12/2016  Patient complainedof easy fatiguability and weakness.  O/E:  HR - 112/min. BP – 100/60. RR – 22/min. SpO2 – 98%. I/O – 477/1000.  Pallor (++)  Bilateral pitting edema (+)  Occasional bilateral basilar crepitations (+)  Patient’s LFT was found to be elevated. USG abdomen was planned and MGE opinion was to be sought after.  Patient was shifted to MMW D4.
  • 15.
    INVESTIGATIONS PATHOLOGY BIOCHEMISTRY BIOCHEMISTRY Hb:4.8 PERIPHERAL SMEAR: Microcytic hypochromic RBCs. Anisopoikilocytosis (+) Elliptocytes (+) TC is raised with neutrophilic predominance. Adequate platelets. No parasites. Reticulocyte count – 2%. SEROLOGY: (-) Urea: 80 Creat: 1.3 Na: 131 K: 5.1, 5.1 SGOT: 1830, 2710 SGPT: 3270, 1942 AlkP: 95, 111 GGT: 83 T.Prot: 6.0 Alb: 3.8 Glob: 2.2 T. Bil: 0.9 Ca: 9.8 Ph: 2.9 Mg: 1.8 Uric acid: 8.6 PT: 30.6 (13.5) INR: 2.42 PTT: 47.5 (32) CPK T: 439 CPK MB: 16
  • 16.
    20/12/16  Patient wassymptomatically stable.  O/E:  HR: 110/min. BP: 110/80 mmHg.  Pallor (++). Icterus (+). B/L Pitting edema (+).  R/S: NVBS. Bil Crepts (+). More on left side.  Repeat CXR was advised. One unit of PRBC was transfused.  USG Abdomen:  Mild fatty liver with GB wall edema. Bilateral simple renal cortical cysts. Minimal left sided pleural effusion.  MGE opinion: Hepatomegaly (+). ?Hemolytic cause to r/o malignancy. ?HCC. To do LDH, AFP and CECT. To add Udiliv and Silybon & stop Propranolol.
  • 17.
    TREATMENT DETAILS  Inj.Furosemide 40 mg IV 1-1-0  Inj. Thiamine 100 mg IV 1-0-1  T. Rifaximin 400 mg PO 1-0-1  T. Propranolol 20 mg PO 1-0-1 (Stopped)  T. Ferrous Sulphate 1 tab PO 1-0-1  T. B-Complex 1 tab PO 1-0-0  Syp. Lactulose 30 ml PO 1-0-1.  Inj. Vitamin K 1 amp. IV 1-0-1.  T. Udiliv 300 mg Po 1-0-1  T. Sliybon 140 mg PO 1-0-1.
  • 18.
    21/12/16  Patient complainedof hiccups.  O/E:  HR: 106/min. BP: 110/80 mmHg.  Pallor (+). Pedal edema (+).  R/S: Bilateral crepts (+)  P/A: Hepatomegaly (+)  2D ECHO:  All chambers dilated. Severe LV dysfunction. LVEF of 21%. Grade III Diastolic dysfunction. Trivial AR and TR. Global hypokinesia of LV. No RWMA. No clots. No vegetations.  Repeat CBC, RFT, SE were sent.
  • 19.
    21/12/16  At 330 pm, patient developed high-grade fever and dyspnea.  O/E:  HR: 119/min. BP: 130/80 mmHg. Temp: 103*F. RR: 22/min. SpO2: 82% on room air and 99% with 40% FiO2.  R/S: NVBS. Bilateral crackles (+).  ABG: Respiratory Alkalosis with metabolic acidosis. (pH – 7.46, pCO2 – 23, pO2 – 136, HCO3 – 17)  ECG: No new ST-T changes. LBBB.  Hb – 6.0. TC – 21,700. Plat – 73,000 (verbal).  Na: 129. K: 4.9. Cl: 102. Urea: 68. Creat: 1.12
  • 20.
    21/12/16  Impression: Sepsis.Anemia in failure. Severe LV dysfunction. Thrombocytopenia for evaluation.  Patient shifted to sick cubicle in MMW D4.  Oxygen support of 25% FiO2.  Urine Routine, Blood and Urine C/S, Rapid card test for Malaria, MP/MF and Dengue Serology sent.  Inj. Cefoperazone + Sulbactam 1.5 g IV BD started.  C. Doxycycline 100 mg PO BD started.
  • 21.
    22/12/16  Patient’s dyspneareduced. C/O Hiccups (+).  O/E:  HR: 108.min. BP: 140/70 mmHg.  R/S: Bilateral crackles reduced.  Inj. Metoclopromide 5 mg IV 1-1-1 added.  Dengue serology (-).  Malaria tests (-).
  • 22.
    INVESTIGATIONS 21/12/16 23/12/16 Hb: 6.0 TC:17,360 Plat: 73,000 Urea: 68 Creat: 1.12 Na: 129 K: 4.9 Cl: 102 Malaria (-) Dengue (-) Urine C/S: Sterile Blood C/S: Coagulase negative Staphylococcus sensitive to all antibiotics except Penicillin & Tetracycline Hb: 7.1 Plat: 71,000 Urea: 41 Creat: 1.19 Na: 132 K: 3.1 Cl: 99 ABG: pH – 7.06 pCO2 – 56 pO2 – 79 HCO3 – 15.9 AFP (-) LDH (+) [4000]
  • 23.
    23/12/16  Patient’s dyspneareduced. Hiccups still (+).  O/E:  HR: 123/min. BP: 110/70 mmHg. SpO2: 98% on 25% FiO2.  R/S: NVBS. Bilateral crackles decreased.  HB: 7.1. Plat: 70,000. RFT and SE normal.  Plan for Cardiology opinion post-rounds.
  • 24.
    23/12/16  Patient foundto be gasping. Call received during rounds at 12:30 pm.  HR: 132/min. SpO2: 85% with 60% FiO2 and steadily falling. Peripheral pulse not palpable.  CPR was immediately started according to ACLS protocol.  Patient was intubated with 6.5’ ET tube.  CPR was continued.  Patient was shifted to ICU for resucitation.  Despite all efforts, patient could not be revived and was declared expired at 13:41.
  • 25.
    CAUSE OF DEATH CONGESTIVE CARDIAC FAILURE  SYSTEMIC HYPERTENSION  MICROCYTIC HYPOCHROMIC ANEMIA  OLD CVA
  • 26.